Skip to main content

Navalign, LLC

SEC CIK
0001820593
Latest filing
Jul 27, 2026

Holdings in Q2 2025

Holdings as of Jun 30, 2025, filed Aug 5, 2025. Long positions only; changes compare share counts with Q1 2025.

Institution overview
Positions
115
+1 vs. Q1 2025
Portfolio value
$362.6M
+$11.8M (+3.4%) vs. Q1 2025
Filed
Aug 5, 2025
SEC
Holdings of Navalign, LLC in Q2 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
Goldman Sachs ETF Tr381430230ULTR SHOR BD ETF6,111$309.0K0.1%+12+0.2%Added–
DISWalt Disney CoStock2,483$307.9K0.1%−115−4.4%ReducedHistory
iShares Tr46434V860TRS FLT RT BD5,550$281.1K0.1%00.0%Unchanged–
SLPSimulations Plus, Inc.COM15,306$267.1K0.1%+15,306NewHistory
LOWLowes Companies IncStock1,149$255.0K0.1%−27−2.3%ReducedHistory
Goldman Sachs ETF Tr381430529ACCES TREASURY2,385$238.9K0.1%+2,385New–
SYKStryker CorpStock597$236.2K0.1%+7+1.2%AddedHistory
SPDR Series Trust78464A201ST STR SP600GRWO2,660$236.1K0.1%−1,801−40.4%Reduced–
State Street SPDR S&P 600 Small Cap Value ETF78464A300ETF2,888$230.3K0.1%−2,166−42.9%Reduced–
Vanguard Scottsdale FDS92206C409SHRT TRM CORP BD2,706$215.1K0.1%00.0%Unchanged–
FASTFastenal CoStock5,024$211.0K0.1%+5,024NewHistory
Invesco QQQ Trust Series I46090E103ETF375$206.7K0.1%+375New–
PEPPepsiCo IncStock1,542$203.6K0.1%+29+1.9%AddedHistory
ALLOAllogene Therapeutics, Inc.COM59,865$67.6K<0.1%00.0%UnchangedHistory
CUECue Biopharma, Inc.COM25,000$17.1K<0.1%00.0%UnchangedHistory

Sold out since Q1 2025 (3)

Positions held at the end of Q1 2025 that are gone from this filing.

Positions of Navalign, LLC sold out since Q1 2025
SecurityClassShares in Q1 2025Value in Q1 2025% of portfolio in Q1 2025History
SPDR Index Shs FDS78463X541ST STR NAT ETF10,575$563.1K0.2%–
iShares Tr464288414NATIONAL MUN ETF4,459$470.2K0.1%–
PFEPfizer IncStock9,227$233.8K0.1%History